InvestorsHub Logo
Post# of 4974280
Next 10
Followers 2434
Posts 91302
Boards Moderated 7
Alias Born 09/12/2003

Re: Sconi13 post# 4787474

Thursday, 05/06/2021 11:19:54 AM

Thursday, May 06, 2021 11:19:54 AM

Post# of 4974280
$QNTA TINY FLOAT. PENDING Escozine FDA IND NEWS in 7 days.

QNTA Tiny SS, company buyback shares and no dilution. Quanta owned multi patents. Its rare to see a biotech company on Pinkyland actual reporting earnings millions of dollars. This stock is still under radar, will becoming a runner like VXRT, OCGN or GNUS from penny to dollars. Imho:))

The moment we've been waiting for IND FDA approval.

announced today that it has filed its final set of data requested by the US Food and Drug Administration (FDA) for its Pre-Investigational New Drug (PIND #150335) filing on its lead drug candidate Escozine® as a COVID-19 therapeutic. Along with the submission of a batch of Escozine® previously announced specifically produced for the FDA, the Company believes that this will be the last submission necessary in order to receive IND designation from the regulatory body in the United States.


https://www.globenewswire.com/news-release/2021/04/13/2209126/0/en/Medolife-Rx-Submits-Final-Data-Set-to-FDA-for-IND-Filing-on-Lead-Drug-Candidate.html

Escozine-HP™ Pretty Pricey and it's Truly a Cancer Cure...

https://escozine.net/

https://medolife.com/escozine-hp/

$QNTA NEWS OUT today...

Medolife Rx Implements Proprietary Electro Solution, Further Increasing Efficacy of Polarization Technology
May 06, 2021 08:00 ET | Source: Quanta, Inc.


https://www.globenewswire.com/news-release/2021/05/06/2224499/0/en/Medolife-Rx-Implements-Proprietary-Electro-Solution-Further-Increasing-Efficacy-of-Polarization-Technology.html

$QNTA All News

https://www.globenewswire.com/en/search/organization/Quanta%CE%B4%2520Inc%C2%A7

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.